Streetbeat News

Stock Prices

NOC

Northrop Grumman's B-21 Raider, the world's first sixth-generation aircraft, is on track to meet its key performance parameter for Average Procurement Unit Cost of $550 million in Base Year 2010 dollars. The aircraft is performing as expected in flight tests, and the government has fixed price production options for the first 21 aircraft, with additional pricing negotiations for 19 more.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:21 pm

AKTX

Akari Therapeutics' recent SEC 13D filing reveals that Charles Steve Theofilos, M.D. has reported a 9.99% stake in the company as of May 31, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:20 pm

CARA

Cara Therapeutics has approved a streamlined operating plan to explore strategic alternatives and maximize shareholder value. The board has approved a workforce reduction of approximately 70%, anticipating $2.6 million in total charges associated with the reduction.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:19 pm

AAPL

Apple Inc (NASDAQ:AAPL) shares are trading lower due to reports that the company has halted work on its next high-end Vision device. Apple is still working on a more affordable Vision product, expected by the end of 2025. Despite recent price target increases from analysts, including JPMorgan, the stock is down 1.10% at $214.29.

Portfolio Pulse from Adam Eckert

June 18, 2024 | 8:18 pm

DLA

Delta Apparel plans to exit its DTG2Go business unit, resulting in the closure of multiple facilities and a workforce reduction of approximately 115 employees. The exit plan is expected to be completed within 120 days.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:17 pm

HAE

Haemonetics has announced a limited market release of its VASCADE MVP XL Vascular Closure Device, which is expected to enhance their product portfolio in the vascular closure market.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:17 pm

CRLBF

CURLF

GTBIF

MSOS

TCNNF

VRNOF

The U.S. cannabis market presents a significant investment opportunity, particularly for multi-state operators (MSOs) like Green Thumb Industries, Curaleaf, Trulieve, Verano, and Cresco. Despite current market volatility and challenges, the potential rescheduling of cannabis and the passage of the SAFER Banking Act could drive substantial growth. The AdvisorShares Pure US Cannabis ETF (MSOS) includes these key players, which are well-positioned for long-term growth.

Portfolio Pulse from Javier Hasse

June 18, 2024 | 8:11 pm

KBH

KB Home has provided its guidance for the 2024 fiscal year, projecting housing revenues between $6.70 billion and $6.90 billion, with an average selling price of $485,000 to $495,000. The company expects homebuilding operating income as a percentage of revenues to be between 11.0% and 11.4%, and a housing gross profit margin of 21.1% to 21.5%. Selling, general, and administrative expenses are projected to be approximately 10.1% of housing revenues, with an effective tax rate of around 23.0%. The ending community count is expected to be between 250 and 255.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:11 pm

KBH

KB Home shares are trading higher following better-than-expected Q2 earnings.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:11 pm

KBH

KB Home (NYSE:KBH) reported Q2 2024 earnings per share of $2.15, surpassing the analyst estimate of $1.78 by 20.79%. The company also reported sales of $1.710 billion, beating the estimate of $1.651 billion by 3.57%, despite a 3.13% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

June 18, 2024 | 8:10 pm